International
The Morning Science

What science found today

‹
 

Research

Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy

Medical Xpress ·

Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy

The Brief

  • Patients with multiple myeloma who developed a serious gastrointestinal side effect after CAR T cell therapy had significantly more CAR T cells persisting in their bloodstream.
  • The findings come from new research from The University of Texas MD Anderson Cancer Center.

Why it matters

It suggests that prolonged persistence of CAR T cells may be linked to serious gut complications after myeloma treatment, which could inform how these patients are monitored.

Who’s affected

  • clinicians treating multiple myeloma patients with CAR T cell therapy
  • patients receiving or considering CAR T cell therapy for multiple myeloma

Patients with multiple myeloma who developed a serious gastrointestinal side effect after treatment with chimeric antigen receptor (CAR) T cell therapy had significantly more CAR T cells persisting in their bloodstream, according to new research from The University of Texas MD…

How do you feel about this?

0 Comments

    Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy – The Morning Science